Edition:
United States

Fate Therapeutics Inc (FATE.OQ)

FATE.OQ on NASDAQ Stock Exchange Global Market

1.90USD
29 Apr 2016
Change (% chg)

$-0.06 (-3.06%)
Prev Close
$1.96
Open
$1.95
Day's High
$1.98
Day's Low
$1.82
Volume
30,120
Avg. Vol
35,264
52-wk High
$8.75
52-wk Low
$1.46

FATE.OQ

Chart for FATE.OQ

About

Fate Therapeutics, Inc. (Fate Therapeutics) is a clinical-stage biopharmaceutical company. The Company is engaged in development of programmed cellular immunotherapies for cancer and immune disorders. The Company's cell therapy pipeline consists of immuno-oncology programs, including cancer immunotherapies derived from... (more)

Overall

Beta: --
Market Cap(Mil.): $54.84
Shares Outstanding(Mil.): 28.86
Dividend: --
Yield (%): --

Financials

  FATE.OQ Industry Sector
P/E (TTM): -- 63.38 45.26
EPS (TTM): -1.21 -- --
ROI: -59.31 5.38 12.52
ROE: -90.37 7.18 13.41
Search Stocks

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Thomson Reuters Stock Report
$25.00
Provider : Wright Reports
$75.00
Provider : ValuEngine, Inc.
$25.00
Provider : Pechala's Reports
$25.00
Provider : Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks